-
China's Xi arrives in Egypt as US sanctions threat looms over Iran links
-
IMF reaches agreement with Senegal on new $2.2 bn loan programme
-
Car bomb at Colombian police station kills one, injures 11
-
Germany blames Russia for airport drone incident, hits back with sanctions
-
Rain delays start of play on US Open
-
Iran president urges return to truce, hails Russian support
-
Man City agree blockbuster deal to sign Chelsea star Fernandez: reports
-
Aster and World Liberty Financial Launch USD1 RWA Boost: Phase 1, Offering 125M $WLFI + 6.25M USD1 in Rewards
-
Alkemya Metacore Secures $50M via Tokenised Equity to Scale Nickel Energy and Security Tech
-
Tronchon sprints to Vuelta stage 10 win, Mas keeps red jersey
-
Man City chase Fernandez, Arsenal sell Jesus on deadline day
-
Germany defender Rudiger announces international retirement
-
EU says Russian 'hybrid attacks' won't halt aid to Ukraine
-
Musk defends AI data centers, slams EU rules at G20
-
Explosives used in sabotage attack on German power lines
-
Activists blame Kenya for Ugandan opposition figure's plight
-
Nepali families hold symbolic funerals for missing after floods
-
Iran president offers US olive branch, hails Russian support
-
Newcastle sign Lille forward Fernandez-Pardo
-
TrustFinance Community Choice Awards 2026 Opens Global Voting
-
Even at Elysee, phones are handed in, Macron tells French pupils
-
Nepal disaster a climate 'warning signal': foreign minister
-
Chelsea agree to sign Atalanta's Ahanor, with Palace loan for this season
-
France winger Diaby returns to Leverkusen until 2031
-
Chelsea sign Atalanta's Ahanor and loan him to Palace
-
Barcelona confirm Jesus arrival from Arsenal
-
UK chalks up hottest summer on record for second year running
-
EU official says it's not time to 'normalize' Russia at G20 finance talks
-
China's Xi visits Egypt as US sanctions threat looms over Iran links
-
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
-
RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology
-
TrendEadvisor Launches Global Multi-Asset Platform Combining Online Investing with Social Trading
-
Global bond sell-off deepens on inflation concerns
-
India's top court drops criminal cases against protesters
-
Germany's far-right AfD promises 'boom' but economists fear worst
-
Philippine couple married in hip-deep floodwaters
-
Former England captain Stokes signs for Adelaide Strikers
-
Villa sign Senegal winger Mbaye from PSG
-
Pakistan selector and ex-captain Misbah resigns after coach sacked
-
Former Peru minister last-minute contender for UN labour agency helm
-
Shein flattens on Hong Kong debut facing global headwinds
-
Messi legacy will 'live forever', says Beckham
-
Eurozone inflation hits three-year high at 3.3% in August
-
'Literally tasting the smoke': Malaysians suffer as haze worsens
-
Man City chase Fernandez, Arsenal eye Alvarez on deadline day
-
Kyiv's defences, 'hybrid' threat from Moscow headline EU talks
-
El Nino hammering Peru anchovy fishing: industry officials
-
Oil extends gains, stocks mostly down as Trump issues fresh Iran warning
-
Mass Russian barrage kills 12 in Kyiv
-
ThinkMarkets Expands Weekend Trading Offering, Launches Weekend League Competition
US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
S.Jackson--AT